For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230215:nRSO9133Pa&default-theme=true
RNS Number : 9133P IDOX PLC 15 February 2023
Idox plc
('Idox' or the 'Group' or the 'Company')
Exercise of Share Options &
Total Voting Rights
Idox plc (AIM: IDOX) a leading supplier of specialist information management
software and solutions to the public and asset-intensive sectors, announces
that it has issued 157,410 new ordinary shares of 1 pence each in the Company
("Ordinary Shares") pursuant to an exercise of options by employees under its
Idox plc Long Term Incentive Plans.
Applications have been made for the 157,410 new Ordinary Shares to be admitted
to trading on AIM ("Admission"). It is expected that Admission will occur at
8.00 a.m. on or around 16 February 2023.
The Company holds no ordinary shares in treasury. The total number of ordinary
shares in issue following Admission will be 453,548,978. Therefore, the total
number of ordinary shares with voting rights in the Company will be
453,548,978.
The above figure of 453,548,978 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the Company under
the FCA's Disclosure and Transparency Rules.
Enquiries:
Idox plc +44 (0) 870 333 7101
Chris Stone, Non-Executive Chairman
David Meaden, Chief Executive
Anoop Kang, Chief Financial Officer
Peel Hunt LLP (NOMAD and Broker) +44 (0) 20 7418 8900
Paul Gillam
Michael Burke
James Smith
MHP Communications +44 (0) 203 128 8276
Reg Hoare idox@mhpc.com
Ollie Hoare
Matthew Taylor
About Idox plc For more information see www.idoxplc.com
(http://www.idoxplc.com/) @Idoxgroup
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVREZLFFXLLZBBB